372 related articles for article (PubMed ID: 16419005)
1. [The kidney in dysproteinemia].
Spanti D; Marcantoni C; Di Landro D
G Ital Nefrol; 2005; 22 Suppl 33():S39-45. PubMed ID: 16419005
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies.
Nasr SH; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Lacy M; Dispenzieri A; Rajkumar SV; Kyle RA; Leung N
Am J Kidney Dis; 2012 Jun; 59(6):786-94. PubMed ID: 22417785
[TBL] [Abstract][Full Text] [Related]
3. [Kidney damage in multiple myeloma and other monoclonal gammopathies].
Adam Z; Pour L; Krejcí M; Stĕpánková S; Svobodová I; Veselý K; Hájek R
Vnitr Lek; 2008 Sep; 54(9):847-61. PubMed ID: 18924346
[TBL] [Abstract][Full Text] [Related]
4. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
5. [Clinical problems in kidney disorders associated with myeloma and other paraproteinemias].
Merta M; Spicka I; Rysavá R; Zabka J; Tesar V; Zima T; Honsová E; Stejskalová A; Vorsilková M; Walterová J
Sb Lek; 1996; 97(4):469-77. PubMed ID: 9424712
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal proteins and renal disease.
Kyle RA
Annu Rev Med; 1994; 45():71-7. PubMed ID: 8198402
[TBL] [Abstract][Full Text] [Related]
7. [Paraproteinemia and renal diseases].
Grandjean AP; Dettwiler S; Saudan P
Rev Med Suisse; 2010 Mar; 6(238):460-6. PubMed ID: 20344997
[TBL] [Abstract][Full Text] [Related]
8. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
[TBL] [Abstract][Full Text] [Related]
9. Renal disease is a prodrome of multiple myeloma: an analysis of 50 patients from eastern India.
Prakash J; Mandal AK; Vohra R; Wani IA; Hota JK; Raja R; Singh U
Ren Fail; 2009; 31(4):267-71. PubMed ID: 19462274
[TBL] [Abstract][Full Text] [Related]
10. Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience.
Stratta P; Gravellone L; Cena T; Rossi D; Gaidano G; Fenoglio R; Lazzarich E; Quaglia M; Airoldi A; Bozzola C; Monga G; Valente G; Canavese C; Magnani C
Crit Rev Oncol Hematol; 2011 Jul; 79(1):31-42. PubMed ID: 20570173
[TBL] [Abstract][Full Text] [Related]
11. The ultrastructural basis of renal pathology in monoclonal gammopathies.
Santostefano M; Zanchelli F; Zaccaria A; Poletti G; Fusaroli M
J Nephrol; 2005; 18(6):659-75. PubMed ID: 16358223
[TBL] [Abstract][Full Text] [Related]
12. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement.
Jacquot C; Saint-Andre JP; Touchard G; Nochy D; D'Auzac de Lamartinie C; Oriol R; Druet P; Bariety J
Clin Nephrol; 1985 Aug; 24(2):93-8. PubMed ID: 3930115
[TBL] [Abstract][Full Text] [Related]
13. [Renal disease in multiple myeloma].
Hiromura K; Nojima Y
Nihon Rinsho; 2007 Dec; 65(12):2229-34. PubMed ID: 18069265
[TBL] [Abstract][Full Text] [Related]
14. [The role of nephrologist in treatment of multiple myeloma].
Kes P; Basić-Jukić N; Jurić I; Brunetta B
Acta Med Croatica; 2008; 62 Suppl 1():37-43. PubMed ID: 18578331
[TBL] [Abstract][Full Text] [Related]
15. The combination of thrombotic microangiopathy and nodular sclerosis in light chain deposition disease.
Kanjanabuch T; Bunruang R; Srisawat N; Lewsuwan S; Kittikovit V; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S248-52. PubMed ID: 17044479
[TBL] [Abstract][Full Text] [Related]
16. [Renal involvement in monoclonal gammopathies].
Spicka I; Merta M; Cieslar P; Stejskalová A
Cas Lek Cesk; 1996 Jun; 135(12):374-7. PubMed ID: 8706074
[TBL] [Abstract][Full Text] [Related]
17. Renal histological lesions and clinical syndromes in multiple myeloma. Renal Immunopathology Group.
Pasquali S; Zucchelli P; Casanova S; Cagnoli L; Confalonieri R; Pozzi C; Banfi G; Lupo A; Bertani T
Clin Nephrol; 1987 May; 27(5):222-8. PubMed ID: 3109793
[TBL] [Abstract][Full Text] [Related]
18. [Renal involvement in monoclonal gammopathy and multiple myeloma].
De Sanctis LB; Sestigiani E; Sgarlato V; Fabbrizio B; Santoro A
G Ital Nefrol; 2010; 27 Suppl 50():S19-33. PubMed ID: 20922692
[TBL] [Abstract][Full Text] [Related]
19. High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease.
Hassoun H; Flombaum C; D'Agati VD; Rafferty BT; Cohen A; Klimek VM; Boruchov A; Kewalramani T; Reich L; Nimer SD; Comenzo RL
Bone Marrow Transplant; 2008 Sep; 42(6):405-12. PubMed ID: 18574442
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
